Peripheral blood draw
Peripheral blood draw is a medical procedure with 23 clinical trials. Currently 8 active trials ongoing. Historical success rate of 50.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
8
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
38.5%
5 of 13 finished
61.5%
8 ended early
8
trials recruiting
23
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors
Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas
Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease
AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
Clinical Trials (23)
Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Central Nervous System Tumors
Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas
Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma
Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease
AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration
Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
Aging, Geriatric Syndromes and Clonal Hematopoiesis
MK-3475 Immunotherapy in Endometrial Carcinoma
Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC
Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
Minimal Residual Disease in Peripheral T-cell Lymphoma
Duvelisib to Combat COVID-19
Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia
Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis
Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors
Shave Margins in Breast Conservation Therapy
Ruxolitinib to Combat COVID-19
The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 23